ECCO 2019 highlights

The sessions at ECCO 2019 were packed full of interesting data highlights and hot topics relevant to the treatment of IBD. In the video above, Professor Stefan Schreiber (Germany), Professor David Rubin (USA), Dr Filip Baert (Belgium) and Professor William Sandborn (USA) discuss their highlights from the meeting including the long-awaited head to head VARSITY study comparing adalimumab with vedolizumab and the maintenance data from the UNIFI study for ustekinumab.